These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24590821)

  • 1. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.
    Mukhopadhyay A; Dasgupta S; Kanti Ray U; Gharami F; Bose CK; Mukhopadhyay S
    Ir J Med Sci; 2015 Mar; 184(1):183-8. PubMed ID: 24590821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
    Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
    Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
    Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
    J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
    Iqbal J; Ali Z; Khan AU; Aziz Z
    Leuk Lymphoma; 2014 Sep; 55(9):2109-13. PubMed ID: 24237577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
    Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
    Heartin E; Walkinshaw S; Clark RE
    Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of imatinib on pregnancy outcome.
    Pye SM; Cortes J; Ault P; Hatfield A; Kantarjian H; Pilot R; Rosti G; Apperley JF
    Blood; 2008 Jun; 111(12):5505-8. PubMed ID: 18322153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
    Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
    Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
    Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy outcome of two patients treated with imatinib.
    Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
    Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the new patient with CML in chronic phase.
    Marin D
    Curr Hematol Malig Rep; 2013 Mar; 8(1):37-42. PubMed ID: 23381448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues of imatinib and pregnancy outcome.
    Apperley J
    J Natl Compr Canc Netw; 2009 Nov; 7(10):1050-8. PubMed ID: 19930974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.
    Sawyers CL; Hochhaus A; Feldman E; Goldman JM; Miller CB; Ottmann OG; Schiffer CA; Talpaz M; Guilhot F; Deininger MW; Fischer T; O'Brien SG; Stone RM; Gambacorti-Passerini CB; Russell NH; Reiffers JJ; Shea TC; Chapuis B; Coutre S; Tura S; Morra E; Larson RA; Saven A; Peschel C; Gratwohl A; Mandelli F; Ben-Am M; Gathmann I; Capdeville R; Paquette RL; Druker BJ
    Blood; 2002 May; 99(10):3530-9. PubMed ID: 11986204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy on imatinib: fatal outcome with meningocele.
    Choudhary DR; Mishra P; Kumar R; Mahapatra M; Choudhry VP
    Ann Oncol; 2006 Jan; 17(1):178-9. PubMed ID: 16291579
    [No Abstract]   [Full Text] [Related]  

  • 15. Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country.
    Medhi K; Raina V; Kumar L; Sharma A; Bakhshi S; Gupta R; Kumar R
    Leuk Lymphoma; 2010 Oct; 51(10):1850-4. PubMed ID: 20849386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
    Kobayashi K; Takebayashi C; Miyata S; Narimatsu H; Kami M
    Intern Med; 2009; 48(5):369-71. PubMed ID: 19252364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate (Gleevec, Glivec): a new therapy for chronic myeloid leukemia and other malignancies.
    Hernández-Boluda JC; Cervantes F
    Drugs Today (Barc); 2002 Sep; 38(9):601-13. PubMed ID: 12582448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on imatinib mesylate in chronic myeloid leukemia.
    Curran MP; Croom KF; Goa KL
    BioDrugs; 2004; 18(3):207-10. PubMed ID: 15161340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia.
    Cervera E; Candelaria M; López-Navarro O; Labardini J; Gonzalez-Fierro A; Taja-Chayeb L; Cortes J; Gordillo-Bastidas D; Dueñas-González A
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):207-12. PubMed ID: 22420986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate.
    Lakshmaiah KC; Bhise R; Purohit S; Abraham LJ; Lokanatha D; Suresh TM; Appaji L; Arunakumari BS; Govindbabu K
    Leuk Lymphoma; 2012 Dec; 53(12):2430-3. PubMed ID: 22607062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.